Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

13.90
Delayed Data
As of Oct 23
 -0.15 / -1.07%
Today’s Change
10.75
Today|||52-Week Range
19.90
-7.64%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close14.05
Today’s open14.05
Day’s range13.85 - 14.15
Volume611,210
Average volume (3 months)750,294
Market cap$1.1B
Dividend yield--
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)+76.52%
Earnings growth (this year)-295.69%
Earnings growth (next 5 years)--
Revenue growth (last year)+22.27%
P/E ratioNM
Price/Sales9.43
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...+0.15+1.12%
XLRNAcceleron Pharma Inc-0.10-0.27%
----
EPZMEpizyme Inc-0.55-3.23%
Data as of 10/23/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$109.6M
Annual profit (last year)-$21.0M
Net profit margin-19.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer &
Chief Scientific Officer
Ganesh Venkataraman Kaundinya
Corporate headquarters
Cambridge, Massachusetts

Forecasts